CL2018002646A1 - Prevención de la adherencia del tejido biológico. - Google Patents

Prevención de la adherencia del tejido biológico.

Info

Publication number
CL2018002646A1
CL2018002646A1 CL2018002646A CL2018002646A CL2018002646A1 CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1 CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A CL2018002646 A CL 2018002646A CL 2018002646 A1 CL2018002646 A1 CL 2018002646A1
Authority
CL
Chile
Prior art keywords
biological tissue
adhesion
self
prevention
assembling peptide
Prior art date
Application number
CL2018002646A
Other languages
English (en)
Spanish (es)
Inventor
Satoru Kobayashi
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of CL2018002646A1 publication Critical patent/CL2018002646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CL2018002646A 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico. CL2018002646A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18

Publications (1)

Publication Number Publication Date
CL2018002646A1 true CL2018002646A1 (es) 2019-07-05

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002646A CL2018002646A1 (es) 2016-03-18 2018-09-14 Prevención de la adherencia del tejido biológico.

Country Status (11)

Country Link
US (4) US20190091376A1 (enExample)
EP (1) EP3429653B1 (enExample)
JP (1) JP7049557B2 (enExample)
KR (1) KR20190022455A (enExample)
CN (1) CN109152868A (enExample)
AU (2) AU2017232540A1 (enExample)
BR (1) BR112018068941A2 (enExample)
CA (1) CA3017684A1 (enExample)
CL (1) CL2018002646A1 (enExample)
MX (1) MX2018011121A (enExample)
WO (1) WO2017158420A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법
JP7442196B2 (ja) 2018-07-03 2024-03-04 株式会社スリー・ディー・マトリックス イオン性自己組織化ペプチド
EP4125995A4 (en) 2020-03-31 2024-04-10 3-D Matrix, Ltd. STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4049671A1 (en) 2004-07-06 2022-08-31 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
AU2006241123B2 (en) * 2005-04-25 2013-10-03 Massachusetts Institute Of Technology Compositions and methods for promoting hemostasis and other physiological activities
BRPI0920030B1 (pt) * 2008-10-06 2019-03-26 3-D Matrix, Ltd. Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
US20210023257A1 (en) 2016-03-18 2021-01-28 3-D Matrix, Ltd. Cerebrospinal fluid leakage occlusion
EP3429646A1 (en) 2016-03-18 2019-01-23 3-D Matrix, Ltd Pancreatic fistula occlusion
KR20190022455A (ko) 2016-03-18 2019-03-06 가부시끼가이샤 쓰리디 매트릭스 생물학적 조직 유착을 방지하는 방법

Also Published As

Publication number Publication date
MX2018011121A (es) 2019-01-31
US12377196B2 (en) 2025-08-05
AU2017232540A1 (en) 2018-09-27
EP3429653B1 (en) 2022-11-09
AU2021225225A1 (en) 2021-09-30
BR112018068941A2 (pt) 2019-04-16
US20220111126A1 (en) 2022-04-14
JP7049557B2 (ja) 2022-04-07
US20190091376A1 (en) 2019-03-28
EP3429653A1 (en) 2019-01-23
JP2019508184A (ja) 2019-03-28
US20230241294A1 (en) 2023-08-03
WO2017158420A1 (en) 2017-09-21
CA3017684A1 (en) 2017-09-21
CN109152868A (zh) 2019-01-04
KR20190022455A (ko) 2019-03-06
US20250177614A1 (en) 2025-06-05

Similar Documents

Publication Publication Date Title
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
MX2017008713A (es) Sujetadores quirurgicos curvados que se usan para fijar dispositivos protesicos en los tejidos.
MX2024000348A (es) Mavacamten para su uso en el tratamiento de la cardiomiopatia hipertrofica.
PE20200748A1 (es) Composiciones de aminoacidos para el tratamiento de lesion neuronal
CL2016001405A1 (es) A peptide mixture
CL2018002644A1 (es) Oclusión fístula pancreática.
CL2020000382A1 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática.
AR078422A1 (es) Un metodo cosmetico para la destruccion de tejido adiposo
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
CY1120642T1 (el) Φαρμακευτικη συνθεση της ιβουπροφαιμνης και της τραμαδολης για οφθαλμολογικη χρηση
CY1119067T1 (el) Διασταυρουμενο υαλουρονικο οξυ, διαδικασια για την παρασκευη του και χρηση αυτου στο αισθητικο πεδιο
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
CY1117854T1 (el) Πεπτιδικη φαρμακοτεχνικη μορφη για τοπικη οφθαλμικη χρηση
MX2018012285A (es) Metodos de tratamiento para enfermedades colestasicas y fibroticas.
MX2019005979A (es) Peptidos modificados.
GB2541854A (en) Patterned surfaces
MX2019006444A (es) Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos.
WO2016040169A3 (en) Mucolytic agents for use in tretaing pulmonary sarcoidosis
MX384262B (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
MX2019000849A (es) Gel intestinal de levodopa y carbidopa y metodos de uso.
EP3787496C0 (en) DETECTION OF IRREGULARITIES IN BREAST TISSUE
CL2018002643A1 (es) Oclusión de fuga de líquido cefalorraquideo.
EP3446723A4 (en) DENTAL TREATMENT MATERIAL AND DENTAL HANDLING KIT
CO2022010207A2 (es) Uso de derivados del ácido hialurónico en la regeneración de tejidos óseos y cartilaginosos